Literature DB >> 30082901

Relative telomere length and prostate cancer mortality.

Wilfried Renner1, Sabine Krenn-Pilko2, Hans-Jürgen Gruber3, Markus Herrmann3, Tanja Langsenlehner2.   

Abstract

PURPOSE: Telomeres are essential for the maintenance of chromosomal integrity and telomere length has been associated with cancer risk and development. Aim of the present study was to analyze the prognostic value of leukocyte relative telomere (RTL) length in long-term prostate cancer (PCa) mortality.
METHODS: Blood samples of PCa patients were obtained before initiation of radiotherapy. RTL of peripheral blood leukocytes was determined by a quantitative polymerase chain reaction method in 533 patients with PCa. Main outcome was overall mortality.
RESULTS: During a median follow-up time of 149 months, 188 (35.3%) patients died. In a univariate Cox regression analysis, RTL quartiles (longer RTL) were significantly associated with higher overall mortality (hazard ration (HR) = 1.20; 95% confidence interval (CI): 1.05-1.36; p = 0.006). In a multivariate Cox regression model including age at diagnosis, androgen deprivation therapy, and risk group (based on PSA level, GS, and T stage), RTL quartiles remained a significant predictor of higher overall mortality (HR = 1.22; 95% CI: 1.07-1.39; p = 0.003).
CONCLUSIONS: Longer leukocyte RTL predicts higher overall mortality in patients with PCa.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30082901     DOI: 10.1038/s41391-018-0068-3

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  7 in total

1.  Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.

Authors:  Junfeng Xu; Wen-Shin Chang; Chia-Wen Tsai; Da-Tian Bau; Yifan Xu; John W Davis; Timothy C Thompson; Christopher J Logothetis; Jian Gu
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

2.  Depressive symptoms and shorter survival in lung cancer: the role of leukocyte telomere length.

Authors:  Chelsea J Siwik; Elizabeth Cash; Sandra E Sephton
Journal:  Psychol Health       Date:  2022-03-03

3.  Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.

Authors:  Benjamin A Rybicki; Sudha M Sadasivan; Yalei Chen; Ian Loveless; Nilesh S Gupta; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang L Tang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-05-04       Impact factor: 4.090

Review 4.  Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer.

Authors:  Konrad Sopyllo; Andrew M Erickson; Tuomas Mirtti
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

5.  The telomere length landscape of prostate cancer.

Authors:  Julie Livingstone; Yu-Jia Shiah; Takafumi N Yamaguchi; Lawrence E Heisler; Vincent Huang; Robert Lesurf; Tsumugi Gebo; Benjamin Carlin; Stefan Eng; Erik Drysdale; Jeffrey Green; Theodorus van der Kwast; Robert G Bristow; Michael Fraser; Paul C Boutros
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

Review 6.  Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer.

Authors:  Ulka N Vaishampayan; Pedro C Barata; Albert Jang; Grant P Rauterkus
Journal:  Onco Targets Ther       Date:  2022-08-26       Impact factor: 4.345

7.  Genetic variations associated with telomere length affect the risk of gastric carcinoma.

Authors:  Ma Lili; Fan Yuxiang; Han Zhongcheng; Su Ying; Chen Ru; Xu Rong; Liu Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.